Background: The treatment of acute cholecystitis has been controversially discussed in the literature as there are no high-evidence-level data yet for determining the optimal point in time for surgical intervention. So far, the laparoscopic removal of the gallbladder within 72 h has been the most preferred approach in acute cholecystitis. Methods: We conducted a systematic review by including randomized trials of early laparoscopic cholecystectomy for acute cholecystitis. Results: Based on a few prospective studies and two meta-analyses, there was consent to prefer an early laparoscopic cholecystectomy for patients suffering from acute calculous cholecystitis while the term ‘early' has not been consistently defined yet. So far, there is new level 1b evidence brought forth by the so-called ‘ACDC' study which has convincingly shown in a prospective randomized setting that immediate laparoscopic cholecystectomy - within a time frame of 24 h after hospital admission - is the smartest approach in ASA I-III patients suffering from acute calculous cholecystitis compared to a more conservative approach with a delayed laparoscopic cholecystectomy after an initial antibiotic treatment in terms of morbidity, length of hospital stay, and overall treatment costs. Concerning critically ill patients suffering from acute calculous or acalculous cholecystitis, there is no consensus in treatment due to missing data in the literature. Conclusion: Laparoscopic cholecystectomy for acute cholecystitis within 24 h after hospital admission is a safe procedure and should be the preferred treatment for ASA I-III patients. In critically ill patients, the intervention should be determined by a narrow interdisciplinary consent based on the patient's individual comorbidities.

Keywords:
Acute cholecystitis, Surgery, Laparoscopic cholecystectomy, Cholecystotomy, Interdisciplinary management
1.
Stinton LM, Shaffer EA: Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver 2012;6:172-187.
2.
Stinton LM, Myers RP, Shaffer EA: Epidemiology of gallstones. Gastroenterol Clin North Am 2010;39:157-169, vii.
3.
Carter HR, Cox RL, Polk HC Jr: Operative therapy for cholecystitis and cholelithiasis: trends over three decades. Am Surg 1987;53:565-568.
4.
Sakorafas GH, Milingos D, Peros G: Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy. Dig Dis Sci 2007;52:1313-1325.
5.
Sobolev B, Mercer D, Brown P, FitzGerald M, Jalink D, Shaw R: Risk of emergency admission while awaiting elective cholecystectomy. CMAJ 2003;169:662-665.
6.
Cheruvu CV, Eyre-Brook IA: Consequences of prolonged wait before gallbladder surgery. Ann R Coll Surg Engl 2002;84:20-22.
7.
Macafee D, Humes DJ, Bouliotis G, Beckingham IJ, Whynes DK, Lobo DN: Prospective randomized trial using cost-utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder disease. Br J Surg 2009;96:1031-1040.
8.
Ito K, Ito H, Whang EE: Timing of cholecystectomy for biliary pancreatitis: do the data support current guidelines? J Gastrointest Surg 2008;12:2164-2170.
9.
Gutt CN: Acute cholecystitis: primarily conservative or operative approach? (Article in German). Chirurg 2013;84:185-190.
10.
Lammert F, Sauerbruch T: Gallensteine. Gastroenterologe 2007;26:461-476.
11.
Johner A, Raymakers A, Wiseman S: Cost utility of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Surg Endosc 2013;27:256-262.
12.
Wilson E, Gurusamy K, Gluud C, Davidson BR: Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2010;97:210-219.
13.
Garner JP, Sood SK, Robinson J, Barber W, Ravi K: The cost of ignoring acute cholecystectomy. Ann R Coll Surg Engl 2009;91:39-42.
14.
Lai P, Kwong KH, Leung KL, Kwok SP, Chan AC, Chung SC, Lau WY: Randomized trial of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 1998;85:764-767.
15.
Lo C-M, Liu CL, Fan ST, Lai EC, Wong J: Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg 1998;227:461-467.
16.
Johansson M, Thune A, Blomqvist A, Nelvin L, Lundell L: Impact of choice of therapeutic strategy for acute cholecystitis on patient's health-related quality of life. Results of a randomized, controlled clinical trial. Dig Surg 2004;21:359-362.
17.
Kolla SB, Aggarwal S, Kumar A, Kumar R, Chumber S, Parshad R, Seenu V: Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a prospective randomized trial. Surg Endosc 2004;18:1323-1327.
18.
Gurusamy KS, Davidson C, Gluud C, Davidson BR: Early versus delayed laparoscopic cholecystectomy for people with acute cholecystitis. Cochrane Database Syst Rev 2013;6:CD005440.
19.
Siddiqui T, MacDonald A, Chong PS, Jenkins JT: Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a meta-analysis of randomized clinical trials. Am J Surg 2008;195:40-47.
20.
Gurusamy K, Samraj K, Gluud C, Wilson E, Davidson BR: Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2010;97:141-150.
21.
Banz V, Gsponer T, Candinas D, Güller U: Population-based analysis of 4113 patients with acute cholecystitis: defining the optimal time-point for laparoscopic cholecystectomy. Ann Surg 2011;254:964-970.
22.
Bree RL: Further observations on the usefulness of the sonographic Murphy sign in the evaluation of suspected acute cholecystitis. J Clin Ultrasound 1995;23:169-172.
23.
Ralls PW, Halls J, Lapin SA, Quinn MF, Morris UL, Boswell W: Prospective evaluation of the sonographic Murphy sign in suspected acute cholecystitis. J Clin Ultrasound 1982;10:113-115.
24.
Singer AJ, McCracken G, Henry MC, Thode HC Jr, Cabahug CJ: Correlation among clinical, laboratory, and hepatobiliary scanning findings in patients with suspected acute cholecystitis. Ann Emerg Med 1996;28:267-272.
25.
Spelsberg FW, Nusser F, Hüttl TK, Obeidat FW, Lang RA, Jauch KW, Hüttl TP: Aktuelle Therapie der Cholezysto- und Choledocholithiasis - Umfrageergebnisse mit Analyse von 16 615 Eingriffen in Bayern. Zentralbl Chir 2009;134:120-126.
26.
Gu MG, Kim TN, Song J, Nam YJ, Lee JY, Park JS: Risk factors and therapeutic outcomes of acute acalculous cholecystitis. Digestion 2014;90:75-80.
27.
Cohen J: Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients. J Antimicrob Chemother 2013;68:490-491.
28.
Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK: Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 2012;40:754-761.
29.
Kalliafas S, Ziegler DW, Flancbaum L, Choban PS: Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg 1998;64:471-475.
30.
Winbladh A, Gullstrand P, Svanvik J, Sandström P: Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB (Oxford) 2009;11:183-193.
31.
Anderson JE, Inui T, Talamini MA, Chang DC: Cholecystostomy offers no survival benefit in patients with acute acalculous cholecystitis and severe sepsis and shock. J Surg Res 2014;190:517-521.
32.
Anderson JE, Chang DC, Talamini MA: A nationwide examination of outcomes of percutaneous cholecystostomy compared with cholecystectomy for acute cholecystitis, 1998-2010. Surg Endosc 2013;27:3406-3411.
33.
Gurusamy KS, Rossi M, Davidson BR: Percutaneous cholecystostomy for high-risk surgical patients with acute calculous cholecystitis. Cochrane Database Syst Rev 2013;8:CD007088.
© 2015 S. Karger GmbH, Freiburg
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.